Thalassemia
A blood condition called thalassemia is inherited and is characterised by the body producing either an abnormal form or insufficient amounts of haemoglobin. The protein that carries oxygen in red blood cells is called haemoglobin. Anemia is brought on by the disorder's large-scale destruction of red blood cells.
- Hemodialysis
- Hemochromatosis
- Idiopathic thrombocytopenic purpura
- Malaise
- Bone marrow transplantation
- Blood transfusion
Related Conference of Thalassemia
Thalassemia Conference Speakers
Recommended Sessions
- Anemia
- Biomarkers in Hematology
- Bleeding Disorders
- Clinical and Experimental Hematology
- Coagulopathies
- Gene and Cell Therapies for Blood Disorders
- Hematologic Malignancies
- Hematology and neurological disorders
- Hematology in COVID-19 patients
- Hematology in Pediatrics
- Hematology-oncology
- Hematopoietic Stem Cell Transplantation
- Hemostasis
- HIV/AIDS
- Immunohematology
- Immunotherapy for Blood Disorders
- Leukemia
- Myeloma
- Rare Blood Disorders
- Thalassemia
- Thrombosis and Hemostasis
Related Journals
Are you interested in
- Advances in Hematologic Malignancies - Blood Disorders 2025 (France)
- Advances in Hemostasis and Thrombosis - Blood Disorders 2025 (France)
- Biomarkers in Hematology and Oncology - Hematology Congress 2026 (Germany)
- Blood Disorders and the Immune System - Blood Disorders 2025 (France)
- Blood Disorders in Aging Populations - Blood Disorders 2025 (France)
- Blood Disorders: Diagnosis and Treatment - Hematology Congress 2026 (Germany)
- Cancer Genomics & Metabolomics - Hematology Congress 2026 (Germany)
- Case Reports in Hematology - Hematology Congress 2026 (Germany)
- Clinical Haematology - Hematology Congress 2026 (Germany)
- Cord Blood Transplantation - Hematology Congress 2026 (Germany)
- Cutting-Edge Research in Blood Disorders - Blood Disorders 2025 (France)
- Digital Imaging in Hematology - Hematology Congress 2026 (Germany)
- Future Trends in Hematology: Artificial Intelligence and Big Data - Blood Disorders 2025 (France)
- Gene Therapy and Genetic Engineering in Hematology - Blood Disorders 2025 (France)
- Haematology and Pharma Industry - Hematology Congress 2026 (Germany)
- Hematologic Cancers - Hematology Congress 2026 (Germany)
- Hematologic Toxicities and Side Effects of Cancer Therapy - Blood Disorders 2025 (France)
- Hematology and Cardio-Oncology - Hematology Congress 2026 (Germany)
- Hematology in Global Health: Addressing Disparities - Blood Disorders 2025 (France)
- Hematology Nursing - Hematology Congress 2026 (Germany)
- Hematology: Diagnostics and Screening - Hematology Congress 2026 (Germany)
- Hematopoietic Malignancies - Hematology Congress 2026 (Germany)
- Immunohematology - Hematology Congress 2026 (Germany)
- Immunotherapy and Cellular Therapies in Hematology - Blood Disorders 2025 (France)
- Innovations in Red Blood Cell Disorders - Blood Disorders 2025 (France)
- Neuro-Hematology - Hematology Congress 2026 (Germany)
- Novel Diagnostic Techniques and Biomarkers in Hematology - Blood Disorders 2025 (France)
- Organ Specific Cancer - Hematology Congress 2026 (Germany)
- Pediatric Hematology - Hematology Congress 2026 (Germany)
- Pediatric Hematology: Challenges and Innovations - Blood Disorders 2025 (France)
- Stem Cell Therapy - Hematology Congress 2026 (Germany)
- Stem Cell Transplantation and Regenerative Medicine - Blood Disorders 2025 (France)
- Transfusion Medicine: Advances and Challenge - Blood Disorders 2025 (France)
- Transfusion Medicines - Hematology Congress 2026 (Germany)
- Vascular Bleeding Disorders - Hematology Congress 2026 (Germany)